Home / Resources / Early Clinical resources

早期临床

精选资源

Empowering the PK Community: Insights from the Phoenix® User Events

博客

Upcoming early clinical webinars

网络研讨会

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am – 10:30am APAC (JST): Thursday, November

网络研讨会

Certara Simcyp 教育网络研讨会系列第 3 部分：利用建模与模拟方法理解消化道中的过饱和溶解现象[日语]

2025 年 11 月 13 日 – 10-11:30am, Japan Time

网络研讨会

Phoenix WinNonlin & PK 申报：行业标准软件实现更智能的 PK/PD 工作流程

2025 年 11 月 18 日 – 11am（美东时间）

Latest early clinical blogs

All Early clinical - Blog

Blog

降低药物开发风险：早期开发中的关键化学、制造和控制（CMC）及基于生理的药代动力学（PBPK）方法

在以下活动中与我们的专家会面

会议

AAPS 2025 PharmSci 360

November 9 - 12, 2025

会议

PHUSE EU Connect

November 16 - 19, 2025 – Hamburg, Germany

现场活动

Phoenix Roadshow 2025 – Basel

2025 年 11 月 19 日

All early clinical resources

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara Products - Certara IQ, Certara Services, Modeling and Simulation - QSP, Publication

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

Empowering the PK Community: Insights from the Phoenix® User Events

Modeling and Simulation - PK/PD, Blog

How To Design a Case Report Form | 7 Best Practice Steps

Certara Products - Pinnacle 21, Data Standards, Blog

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Certara Services, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Publication

in silico Safety and Toxicology assessment: ToxStudio®

Drug Safety, Webinar

CRF Creator Fact Sheet

Certara Products - Pinnacle 21, Fact Sheet

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Biologics, Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

Best Practices for AI Prompt Engineering in Life Sciences in 2025

Certara Products, Certara.AI, Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

Certara Products - Certara IQ, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Blog

1
2
3
……
59
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

早期临床

最新资源

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Build investor confidence with science-backed strategy

Certara Automates Scientific Workflows with Phoenix® Cloud

精选资源

Empowering the PK Community: Insights from the Phoenix® User Events

Upcoming early clinical webinars

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Certara Simcyp 教育网络研讨会系列第 3 部分：利用建模与模拟方法理解消化道中的过饱和溶解现象[日语]

Phoenix WinNonlin & PK 申报：行业标准软件实现更智能的 PK/PD 工作流程

Latest early clinical blogs

药物开发中 PK/PD 建模的机器学习

美国 FDA MIDD 配对试点计划如何帮助赞助商

揭秘临床 DDI 研究：精准测量代谢产物

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

细胞疗法开发的主要考虑因素

降低药物开发风险：早期开发中的关键化学、制造和控制（CMC）及基于生理的药代动力学（PBPK）方法

在以下活动中与我们的专家会面

AAPS 2025 PharmSci 360

PHUSE EU Connect

Phoenix Roadshow 2025 – Basel

All early clinical resources

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Build investor confidence with science-backed strategy

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Empowering the PK Community: Insights from the Phoenix® User Events

How To Design a Case Report Form | 7 Best Practice Steps

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

in silico Safety and Toxicology assessment: ToxStudio®

CRF Creator Fact Sheet

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Best Practices for AI Prompt Engineering in Life Sciences in 2025

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

订阅时事通讯

快捷链接

解决方案

联系我们